Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.00 (0.00%)
Bid:
72.40
Ask:
73.00
Spread: 0.60 (0.829%)
Market Cap: €11.59b
KYGA Live PriceLast checked at - London Stock Exchange

Intraday Kerry Share Chart

Launch of Share Buyback Programme

17 Feb 2026 07:30

RNS Number : 2371T
Kerry Group PLC
17 February 2026
 

 

 

17 February 2026

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP PLC

Kerry Group plc announces €300m share buyback programme.

On 17 February 2026, Kerry Group plc ("Kerry" or the "Company") announced its intention to launch a new share buyback programme of up to €300 million (the "Buyback Programme"). The Buyback Programme is underpinned by the Group's strong balance sheet and cash flow and is aligned to Kerry's Capital Allocation Framework.

Kerry announces that, pursuant to the Buyback Programme, it has entered into non-discretionary instructions with J&E Davy ("Davy") to purchase up to €300 million of Kerry's A Ordinary Shares of €0.125 each (the "Shares") on its behalf, and to make trading decisions under the Buyback Programme independently of Kerry in accordance with certain pre-set parameters.

The Buyback Programme will commence on 17 February 2026 and will end on 31 December 2026 at the latest. All Shares will be purchased by Davy on the Company's behalf (on a riskless principal basis) on Euronext Dublin for subsequent repurchase by the Company on Euronext Dublin.

The purpose of the Buyback Programme is to reduce the share capital of the Company and as such, the Company will cancel any Shares repurchased.

The Buyback Programme will be conducted within certain pre-set parameters and within the limitations of the authority granted at Kerry's Annual General Meeting on 1 May 2025 ("2025 AGM") up to a maximum number of 16,489,274 Shares. Following the expiry of the 2025 AGM repurchase authority, the continuation of the Buyback Programme will be conditional on shareholder approval of an authority to repurchase Shares at the AGM to be held on 30 April 2026.

The Buyback Programme will be conducted in accordance with the relevant provisions of the Market Abuse Regulation 596/2014/EU ("MAR" and including MAR as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and the Commission Delegated Regulation (EU) 2016/1052 (including as in force in the UK and as amended by the FCA's Technical Standards (Market Abuse Regulation) (EU Exit) Instrument 2019) as well as the rules of the Central Bank of Ireland.

Any repurchase of Shares will be announced no later than 7:30 am on the business day following the calendar day on which the repurchase occurred.

 

CONTACT INFORMATION

GROUP SECRETARY

Ronan Deasy

+353 66 7182000 | GroupCoSec@kerry.ie

WEBSITE

www.kerry.com

 

​Kerry Group | Regulatory Announcement 2026

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGPURWPUPQGMQ
Date   Source Headline
2nd Jun 20269:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
22nd May 20266:04 pmRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
1st May 202610:07 amRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20264:58 pmRNSResult of AGM
30th Apr 20267:00 amRNSQ1 Interim Management Statement 2026
27th Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:40 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 202611:13 amRNSNotice of 2026 AGM
24th Mar 20263:36 pmRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 202611:00 amRNSAnnual Financial Report
16th Mar 20261:33 pmRNSIssuance of Equity Securities
16th Mar 20261:33 pmRNSIssuance of Equity Securities
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20261:16 pmRNSDirector/PDMR Shareholding
4th Mar 20261:14 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20268:23 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20265:06 pmRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 202610:13 amRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20263:28 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.